Skip to main content
. 1999 Nov;43(11):2793–2797. doi: 10.1128/aac.43.11.2793

TABLE 3.

Subjects with treatment-emergent adverse events

Body system and adverse event No. of subjects in treatment group with adverse event
Moxifloxacin, 400 mg (n = 10) Placebo (n = 5)
Any adverse event 8 4
Whole body (total) 3 2
 Abdominal pain 1 1
 Arm pain 1 0
 Headache 2 1
Digestive system (total) 6 2
 Diarrhea 3 2
 Dry mouth 2 0
 Dyspepsia 1 0
 Flatulence 1 0
 Nausea 3 1
 Tooth pain 1 0
Nervous system, dizziness 1 1
Respiratory tract, rhinitis 3 0
Skin and appendages, acne 1 0